Lataa...

Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma

PURPOSE: Minimal residual disease (MRD) presents a significant hurdle to curing metastatic neuroblastoma (NB). Biologic therapies directed against MRD can improve outcome. Evaluating treatment efficacy requires MRD measurement, which serves as surrogate endpoint. Because of tumor heterogeneity, no s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cheung, Irene Y., Feng, Yi, Gerald, William, Cheung, Nai-Kong V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2008
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670609/
https://ncbi.nlm.nih.gov/pubmed/18980998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0541
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!